Related Experiment Video
Updated: Aug 11, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Oral contraceptives and increased headache prevalence: the Head-HUNT Study
K Aegidius1, J-A Zwart, K Hagen
1Department of Neuroscience, Norwegian National Headache Centre, St. Olav's University Hospital, Trondheim, Norway. k.aegidius@dadlnet.dk
Objective:
To examine the prevalence of headache and migraine among women using oral contraceptives (OCs) in a large, cross-sectional population-based study.
Methods:
In the Nord-Trøndelag Health Study in Norway 1995-1997 (HUNT 2), 27,700 (60%) out of 46,506 invited women responded to headache questions (Head-HUNT). Among 14,353 premenopausal women, 13,944 (97%) responded to questions regarding use of contraceptives.
Results:
There was a significant association between headache and reported use of estrogen-containing OCs in premenopausal women, both for migraine (OR = 1.4, 95% CI = 1.2 to 1.7) and for non-migrainous headache (OR = 1.2, 95% CI = 1.0 to 1.4). A significant dose relationship between headache and the amount of estrogen in the OCs could not be demonstrated. No significant association between headache and OCs containing only gestagen was found.
Conclusion:
Headache, especially migraine, was more likely among premenopausal women using oral contraceptives containing estrogen.
Related Concept Videos
Increased Intracranial Pressure l: Introduction
Birth Control Methods
